Adjunctive Brexpiprazole 1 and 3 mg for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants: A Phase 3, Randomized, Double-Blind Study
Year: 2015
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
DOI: 10.4088/jcp.14m09689
Institution: University of Pennsylvania
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: brexpiprazole, major depressive disorder, inadequate response to antidepressants, adjunctive therapy, atypical antipsychotics, akathisia, antipsychotic adverse effects, treatment-resistant depression, antidepressant efficacy, functional disability, weight gain, dose comparison, Montgomery-Asberg Depression Rating Scale, Sheehan Disability Scale
Open Access status: closed
OpenAlex ID: W2140725933
